It has also been shown to be a potent pure AR antagonist that prevents the binding of synthetic androgen methyltrienolone to both the mutant prostate adenocarcinoma LNCaP AR and the wild-type AR. The gene discussed is AR; the disease is prostate adenocarcinoma.